All the news articles and press releases in one place.

Search
Date / Time Source Ticker Company Sector Market Cap Announcement
16Jul18 07:00 RNS AV:LON, RENE:LON Aviva plc, ReNeuron Group plc Various Various Notification of Major Holdings
13Jul18 11:50 RNS AV:LON, RENE:LON Aviva plc, ReNeuron Group plc Various Various Notification of Major Holdings
12Jul18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Preliminary Results
11Jul18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Signs retinal stem cell exclusivity agreement
04Jul18 14:15 RNS RENE:LON ReNeuron Group plc Health £1.74m Notification of Preliminary Results
17May18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Capital Markets Event
04May18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Exosome data presented at ISCT conference
30Apr18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Capital Markets Event and Webcast
19Apr18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Wins grant for retinal cell therapy development
10Apr18 13:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Appointment of US-based Chief Medical Officer
26Mar18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Product Development Update
13Feb18 10:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Positive pre-clinical data in nerve injury
23Jan18 11:06 RNS RENE:LON ReNeuron Group plc Health £1.74m Approval of Share Capital Reorganisation
11Jan18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Further re Share Capital Reorganisation
05Jan18 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Proposed Share Capital Reorganisation
14Dec17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Interim results
14Dec17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Stroke clinical trial regulatory approval in US
08Dec17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m ReNeuron opens US office
13Nov17 11:30 RNS RENE:LON ReNeuron Group plc Health £1.74m Notification of Interim Results
08Nov17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Retinal disease clinical trial moves into Phase II
31Oct17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Positive stroke clinical data & regulatory update
27Oct17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Wins further UK grant
11Oct17 13:31 RNS RENE:LON ReNeuron Group plc Health £1.74m PDMR Interest in Shares and Share Options
09Oct17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Presentation of positive pre-clinical data
12Sep17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Directors' Interest in Shares and Share Options
06Sep17 11:15 RNS RENE:LON ReNeuron Group plc Health £1.74m Result of AGM
06Sep17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m AGM Trading Update
01Sep17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Non-executive Director Appointment
07Aug17 15:04 RNS RENE:LON ReNeuron Group plc Health £1.74m Posting of Annual Report and Notice of AGM
25Jul17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Appointment of joint broker
19Jul17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Board change
29Jun17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Preliminary Results
19Jun17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m FDA approves cryopreserved hRPC formulation
08Jun17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Notification of Preliminary Results
05Jun17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Positive FDA feedback on proposed Phase III study
18May17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Presents positive exosome data at major conference
11May17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Awarded major UK cell therapy manufacturing grant
05May17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Presents new exosome data at major conference
21Apr17 07:01 RNS RENE:LON ReNeuron Group plc Health £1.74m Update on clinical strategy in stroke disability
21Apr17 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Update on progress in ophthalmology programmes
07Feb17 12:32 RNS RENE:LON ReNeuron Group plc Health £1.74m Director Share Purchase
14Dec16 12:15 RNS RENE:LON ReNeuron Group plc Health £1.74m Director Share Purchase
05Dec16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Reports Positive Results in Phase II Stroke Trial
05Dec16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Interim Results
14Nov16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Notification of Interim Results
05Oct16 14:30 RNS RENE:LON ReNeuron Group plc Health £1.74m Notification of Major Interest in Shares
06Sep16 12:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Result of AGM
06Sep16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m AGM Trading Update
05Aug16 16:35 RNS RENE:LON ReNeuron Group plc Health £1.74m Posting of Annual Report and Notice of AGM
04Aug16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Stroke clinical data published in The Lancet
22Jul16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Publication of positive pre-clinical retinal data
20Jul16 14:31 RNS RENE:LON ReNeuron Group plc Health £1.74m Directors' Interest in Shares and Share Options
07Jul16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Preliminary Results
14Jun16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Notification of Preliminary Results
13Jun16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Patient recruitment completed in stroke trial
09Jun16 07:01 RNS RENE:LON ReNeuron Group plc Health £1.74m Pursues brain cancer with exosome platform
08Jun16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Retinitis pigmentosa update & Notice of KOL event
31May16 12:45 RNS RENE:LON ReNeuron Group plc Health £1.74m Change of Adviser
15Mar16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m First Patient Treated in RP Clinical Trial
23Feb16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m ReNeuron Relocates to South Wales
17Feb16 16:57 RNS RENE:LON ReNeuron Group plc Health £1.74m Director's Dealings
03Feb16 10:07 RNS RENE:LON ReNeuron Group plc Health £1.74m Director Share Purchase
01Feb16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Notice of Grant of Key US Patent
12Jan16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Pre-clinical data relating to exosome platform
11Jan16 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Wins UK grant to advance its exosome platform
17Dec15 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m ReNeuron establishes Scientific Advisory Board
07Dec15 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Interim Results
04Dec15 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m Non-executive Director appointment
12Nov15 14:45 RNS RENE:LON ReNeuron Group plc Health £1.74m Notification of Interim Results
06Nov15 15:29 RNS RENE:LON ReNeuron Group plc Health £1.74m Total Voting Rights
02Oct15 15:01 RNS RENE:LON ReNeuron Group plc Health £1.74m Directors' Interest in Shares and Share Options
14Jun12 07:00 RNS RENE:LON ReNeuron Group plc Health £1.74m PISCES Trial Interim Data
Date / Time Source Company % Chg
16Jul18 07:00 RNS Aviva plc, ReNeuron Group plc 0.54%
Notification of Major Holdings
13Jul18 11:50 RNS Aviva plc, ReNeuron Group plc 0.54%
Notification of Major Holdings
12Jul18 07:00 RNS ReNeuron Group plc 0.00%
Preliminary Results
11Jul18 07:00 RNS ReNeuron Group plc 0.00%
Signs retinal stem cell exclusivity agreement
04Jul18 14:15 RNS ReNeuron Group plc 0.00%
Notification of Preliminary Results
17May18 07:00 RNS ReNeuron Group plc 0.00%
Capital Markets Event
04May18 07:00 RNS ReNeuron Group plc 0.00%
Exosome data presented at ISCT conference
30Apr18 07:00 RNS ReNeuron Group plc 0.00%
Capital Markets Event and Webcast
19Apr18 07:00 RNS ReNeuron Group plc 0.00%
Wins grant for retinal cell therapy development
10Apr18 13:00 RNS ReNeuron Group plc 0.00%
Appointment of US-based Chief Medical Officer
26Mar18 07:00 RNS ReNeuron Group plc 0.00%
Product Development Update
13Feb18 10:00 RNS ReNeuron Group plc 0.00%
Positive pre-clinical data in nerve injury
23Jan18 11:06 RNS ReNeuron Group plc 0.00%
Approval of Share Capital Reorganisation
11Jan18 07:00 RNS ReNeuron Group plc 0.00%
Further re Share Capital Reorganisation
05Jan18 07:00 RNS ReNeuron Group plc 0.00%
Proposed Share Capital Reorganisation
14Dec17 07:00 RNS ReNeuron Group plc 0.00%
Interim results
14Dec17 07:00 RNS ReNeuron Group plc 0.00%
Stroke clinical trial regulatory approval in US
08Dec17 07:00 RNS ReNeuron Group plc 0.00%
ReNeuron opens US office
13Nov17 11:30 RNS ReNeuron Group plc 0.00%
Notification of Interim Results
08Nov17 07:00 RNS ReNeuron Group plc 0.00%
Retinal disease clinical trial moves into Phase II
31Oct17 07:00 RNS ReNeuron Group plc 0.00%
Positive stroke clinical data & regulatory update
27Oct17 07:00 RNS ReNeuron Group plc 0.00%
Wins further UK grant
11Oct17 13:31 RNS ReNeuron Group plc 0.00%
PDMR Interest in Shares and Share Options
09Oct17 07:00 RNS ReNeuron Group plc 0.00%
Presentation of positive pre-clinical data
12Sep17 07:00 RNS ReNeuron Group plc 0.00%
Directors' Interest in Shares and Share Options
06Sep17 11:15 RNS ReNeuron Group plc 0.00%
Result of AGM
06Sep17 07:00 RNS ReNeuron Group plc 0.00%
AGM Trading Update
01Sep17 07:00 RNS ReNeuron Group plc 0.00%
Non-executive Director Appointment
07Aug17 15:04 RNS ReNeuron Group plc 0.00%
Posting of Annual Report and Notice of AGM
25Jul17 07:00 RNS ReNeuron Group plc 0.00%
Appointment of joint broker
19Jul17 07:00 RNS ReNeuron Group plc 0.00%
Board change
29Jun17 07:00 RNS ReNeuron Group plc 0.00%
Preliminary Results
19Jun17 07:00 RNS ReNeuron Group plc 0.00%
FDA approves cryopreserved hRPC formulation
08Jun17 07:00 RNS ReNeuron Group plc 0.00%
Notification of Preliminary Results
05Jun17 07:00 RNS ReNeuron Group plc 0.00%
Positive FDA feedback on proposed Phase III study
18May17 07:00 RNS ReNeuron Group plc 0.00%
Presents positive exosome data at major conference
11May17 07:00 RNS ReNeuron Group plc 0.00%
Awarded major UK cell therapy manufacturing grant
05May17 07:00 RNS ReNeuron Group plc 0.00%
Presents new exosome data at major conference
21Apr17 07:01 RNS ReNeuron Group plc 0.00%
Update on clinical strategy in stroke disability
21Apr17 07:00 RNS ReNeuron Group plc 0.00%
Update on progress in ophthalmology programmes
07Feb17 12:32 RNS ReNeuron Group plc 0.00%
Director Share Purchase
14Dec16 12:15 RNS ReNeuron Group plc 0.00%
Director Share Purchase
05Dec16 07:00 RNS ReNeuron Group plc 0.00%
Reports Positive Results in Phase II Stroke Trial
05Dec16 07:00 RNS ReNeuron Group plc 0.00%
Interim Results
14Nov16 07:00 RNS ReNeuron Group plc 0.00%
Notification of Interim Results
05Oct16 14:30 RNS ReNeuron Group plc 0.00%
Notification of Major Interest in Shares
06Sep16 12:00 RNS ReNeuron Group plc 0.00%
Result of AGM
06Sep16 07:00 RNS ReNeuron Group plc 0.00%
AGM Trading Update
05Aug16 16:35 RNS ReNeuron Group plc 0.00%
Posting of Annual Report and Notice of AGM
04Aug16 07:00 RNS ReNeuron Group plc 0.00%
Stroke clinical data published in The Lancet
22Jul16 07:00 RNS ReNeuron Group plc 0.00%
Publication of positive pre-clinical retinal data
20Jul16 14:31 RNS ReNeuron Group plc 0.00%
Directors' Interest in Shares and Share Options
07Jul16 07:00 RNS ReNeuron Group plc 0.00%
Preliminary Results
14Jun16 07:00 RNS ReNeuron Group plc 0.00%
Notification of Preliminary Results
13Jun16 07:00 RNS ReNeuron Group plc 0.00%
Patient recruitment completed in stroke trial
09Jun16 07:01 RNS ReNeuron Group plc 0.00%
Pursues brain cancer with exosome platform
08Jun16 07:00 RNS ReNeuron Group plc 0.00%
Retinitis pigmentosa update & Notice of KOL event
31May16 12:45 RNS ReNeuron Group plc 0.00%
Change of Adviser
15Mar16 07:00 RNS ReNeuron Group plc 0.00%
First Patient Treated in RP Clinical Trial
23Feb16 07:00 RNS ReNeuron Group plc 0.00%
ReNeuron Relocates to South Wales
17Feb16 16:57 RNS ReNeuron Group plc 0.00%
Director's Dealings
03Feb16 10:07 RNS ReNeuron Group plc 0.00%
Director Share Purchase
01Feb16 07:00 RNS ReNeuron Group plc 0.00%
Notice of Grant of Key US Patent
12Jan16 07:00 RNS ReNeuron Group plc 0.00%
Pre-clinical data relating to exosome platform
11Jan16 07:00 RNS ReNeuron Group plc 0.00%
Wins UK grant to advance its exosome platform
17Dec15 07:00 RNS ReNeuron Group plc 0.00%
ReNeuron establishes Scientific Advisory Board
07Dec15 07:00 RNS ReNeuron Group plc 0.00%
Interim Results
04Dec15 07:00 RNS ReNeuron Group plc 0.00%
Non-executive Director appointment
12Nov15 14:45 RNS ReNeuron Group plc 0.00%
Notification of Interim Results
06Nov15 15:29 RNS ReNeuron Group plc 0.00%
Total Voting Rights
02Oct15 15:01 RNS ReNeuron Group plc 0.00%
Directors' Interest in Shares and Share Options
14Jun12 07:00 RNS ReNeuron Group plc 0.00%
PISCES Trial Interim Data
Date / Time Company % Chg
16Jul18 07:00 AV. LSE,RENE LSE 0.54%
Notification of Major Holdings
13Jul18 11:50 AV. LSE,RENE LSE 0.54%
Notification of Major Holdings
12Jul18 07:00 ReNeuron Group plc 0.00%
Preliminary Results
11Jul18 07:00 ReNeuron Group plc 0.00%
Signs retinal stem cell exclusivity agreement
04Jul18 14:15 ReNeuron Group plc 0.00%
Notification of Preliminary Results
17May18 07:00 ReNeuron Group plc 0.00%
Capital Markets Event
04May18 07:00 ReNeuron Group plc 0.00%
Exosome data presented at ISCT conference
30Apr18 07:00 ReNeuron Group plc 0.00%
Capital Markets Event and Webcast
19Apr18 07:00 ReNeuron Group plc 0.00%
Wins grant for retinal cell therapy development
10Apr18 13:00 ReNeuron Group plc 0.00%
Appointment of US-based Chief Medical Officer
26Mar18 07:00 ReNeuron Group plc 0.00%
Product Development Update
13Feb18 10:00 ReNeuron Group plc 0.00%
Positive pre-clinical data in nerve injury
23Jan18 11:06 ReNeuron Group plc 0.00%
Approval of Share Capital Reorganisation
11Jan18 07:00 ReNeuron Group plc 0.00%
Further re Share Capital Reorganisation
05Jan18 07:00 ReNeuron Group plc 0.00%
Proposed Share Capital Reorganisation
14Dec17 07:00 ReNeuron Group plc 0.00%
Interim results
14Dec17 07:00 ReNeuron Group plc 0.00%
Stroke clinical trial regulatory approval in US
08Dec17 07:00 ReNeuron Group plc 0.00%
ReNeuron opens US office
13Nov17 11:30 ReNeuron Group plc 0.00%
Notification of Interim Results
08Nov17 07:00 ReNeuron Group plc 0.00%
Retinal disease clinical trial moves into Phase II
31Oct17 07:00 ReNeuron Group plc 0.00%
Positive stroke clinical data & regulatory update
27Oct17 07:00 ReNeuron Group plc 0.00%
Wins further UK grant
11Oct17 13:31 ReNeuron Group plc 0.00%
PDMR Interest in Shares and Share Options
09Oct17 07:00 ReNeuron Group plc 0.00%
Presentation of positive pre-clinical data
12Sep17 07:00 ReNeuron Group plc 0.00%
Directors' Interest in Shares and Share Options
06Sep17 11:15 ReNeuron Group plc 0.00%
Result of AGM
06Sep17 07:00 ReNeuron Group plc 0.00%
AGM Trading Update
01Sep17 07:00 ReNeuron Group plc 0.00%
Non-executive Director Appointment
07Aug17 15:04 ReNeuron Group plc 0.00%
Posting of Annual Report and Notice of AGM
25Jul17 07:00 ReNeuron Group plc 0.00%
Appointment of joint broker
19Jul17 07:00 ReNeuron Group plc 0.00%
Board change
29Jun17 07:00 ReNeuron Group plc 0.00%
Preliminary Results
19Jun17 07:00 ReNeuron Group plc 0.00%
FDA approves cryopreserved hRPC formulation
08Jun17 07:00 ReNeuron Group plc 0.00%
Notification of Preliminary Results
05Jun17 07:00 ReNeuron Group plc 0.00%
Positive FDA feedback on proposed Phase III study
18May17 07:00 ReNeuron Group plc 0.00%
Presents positive exosome data at major conference
11May17 07:00 ReNeuron Group plc 0.00%
Awarded major UK cell therapy manufacturing grant
05May17 07:00 ReNeuron Group plc 0.00%
Presents new exosome data at major conference
21Apr17 07:01 ReNeuron Group plc 0.00%
Update on clinical strategy in stroke disability
21Apr17 07:00 ReNeuron Group plc 0.00%
Update on progress in ophthalmology programmes
07Feb17 12:32 ReNeuron Group plc 0.00%
Director Share Purchase
14Dec16 12:15 ReNeuron Group plc 0.00%
Director Share Purchase
05Dec16 07:00 ReNeuron Group plc 0.00%
Reports Positive Results in Phase II Stroke Trial
05Dec16 07:00 ReNeuron Group plc 0.00%
Interim Results
14Nov16 07:00 ReNeuron Group plc 0.00%
Notification of Interim Results
05Oct16 14:30 ReNeuron Group plc 0.00%
Notification of Major Interest in Shares
06Sep16 12:00 ReNeuron Group plc 0.00%
Result of AGM
06Sep16 07:00 ReNeuron Group plc 0.00%
AGM Trading Update
05Aug16 16:35 ReNeuron Group plc 0.00%
Posting of Annual Report and Notice of AGM
04Aug16 07:00 ReNeuron Group plc 0.00%
Stroke clinical data published in The Lancet
22Jul16 07:00 ReNeuron Group plc 0.00%
Publication of positive pre-clinical retinal data
20Jul16 14:31 ReNeuron Group plc 0.00%
Directors' Interest in Shares and Share Options
07Jul16 07:00 ReNeuron Group plc 0.00%
Preliminary Results
14Jun16 07:00 ReNeuron Group plc 0.00%
Notification of Preliminary Results
13Jun16 07:00 ReNeuron Group plc 0.00%
Patient recruitment completed in stroke trial
09Jun16 07:01 ReNeuron Group plc 0.00%
Pursues brain cancer with exosome platform
08Jun16 07:00 ReNeuron Group plc 0.00%
Retinitis pigmentosa update & Notice of KOL event
31May16 12:45 ReNeuron Group plc 0.00%
Change of Adviser
15Mar16 07:00 ReNeuron Group plc 0.00%
First Patient Treated in RP Clinical Trial
23Feb16 07:00 ReNeuron Group plc 0.00%
ReNeuron Relocates to South Wales
17Feb16 16:57 ReNeuron Group plc 0.00%
Director's Dealings
03Feb16 10:07 ReNeuron Group plc 0.00%
Director Share Purchase
01Feb16 07:00 ReNeuron Group plc 0.00%
Notice of Grant of Key US Patent
12Jan16 07:00 ReNeuron Group plc 0.00%
Pre-clinical data relating to exosome platform
11Jan16 07:00 ReNeuron Group plc 0.00%
Wins UK grant to advance its exosome platform
17Dec15 07:00 ReNeuron Group plc 0.00%
ReNeuron establishes Scientific Advisory Board
07Dec15 07:00 ReNeuron Group plc 0.00%
Interim Results
04Dec15 07:00 ReNeuron Group plc 0.00%
Non-executive Director appointment
12Nov15 14:45 ReNeuron Group plc 0.00%
Notification of Interim Results
06Nov15 15:29 ReNeuron Group plc 0.00%
Total Voting Rights
02Oct15 15:01 ReNeuron Group plc 0.00%
Directors' Interest in Shares and Share Options
14Jun12 07:00 ReNeuron Group plc 0.00%
PISCES Trial Interim Data